Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy. [electronic resource]
Producer: 19991008Description: 19-24 p. digitalISSN:- 0268-3369
- Adenocarcinoma -- drug therapy
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Cisplatin -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Epirubicin -- therapeutic use
- Erythropoietin -- therapeutic use
- Etoposide -- therapeutic use
- Female
- Fluorouracil -- therapeutic use
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Hematopoietic Stem Cell Mobilization -- adverse effects
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Ifosfamide -- therapeutic use
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Prospective Studies
- Recombinant Proteins
- Transplantation Conditioning -- methods
- Transplantation, Autologous -- methods
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.